Living in polluted city for ten years increases risk of lung disease as much as pack of cigarettes a day for 29 years
August 14, 2019Research and Development Air pollution, COPD, lung disease, pharma emphysema, public health
Air pollution in cities dramatically increases the risk for and risk of progression of emphysema, a form of chronic obstructive …
Senate Finance Comittee Chairman, Chuck Grassley calls on Novartis to reveal details of data scandal
August 13, 2019Research and Development AveXis, Chuck Grassley, Novartis, Zolgensma, sfc
Chuck Grassley, Chairman of the Senate Finance Committee, has demanded that Novartis give up details on the faulty data scandal …
Making things personal: Roche and personalised medicine
August 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, feature, personalised medicine, pharma
Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to patient …
MSD teams up with Harvard University to discover novel immune system pathways to fight cancer
August 13, 2019Manufacturing and Production, Research and Development Cancer, Harvard, MSD, Merck, immuno-oncology, oncology, pharma
A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path …
Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use
August 13, 2019Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma
The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …
Chlamydia vaccine proves safe in Phase 1 trial
August 13, 2019Manufacturing and Production chlamydia, clinicla trials, infectious diseases, pharma, vaccines
A chlamydia vaccine has shown to be safe in a Phase 1 clinical trial, according to a study published in …
Ebola drugs prove 90% effective in clinical trial in DRC
August 13, 2019Manufacturing and Production, Research and Development Congo, DRC, Ebola, clinical trials, infectious diseases, niaid, pharma
Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, …
Scotland turns down Vertex’s Orkambi
August 13, 2019Manufacturing and Production Orkambi, SMC, Scotland, Vertex, cystic fibrosis, pharma
The Scottish Medicines Consortium (SMC) has turned down Vertex’ cystic fibrosis drug Orkambi on the grounds that it is not …
Brammer Bio to set up new plant in Norton, Massachusetts
August 12, 2019Sales and Marketing Brammer Bio, Massachusetts, US, norton, pharma
Cambridge, Massachusetts-based Brammer Bio is planning to set up a new manufacturing facility in Norton, Massachusetts. The Thermo Fisher subsidiary …
FDA-approved drug could be used to treat Ebola, study shows
August 12, 2019Sales and Marketing Ebolas, FDA, Romark, nitazoxanide, pharma, virus
The FDA-approved anti-parasitic drug nitazoxanide could be used as a treatment for Ebola, according to researchers from the Boston Children’s …
EU unprepared for no-deal Brexit, health experts warn
August 12, 2019Sales and Marketing EU, Euroepan Union, UK, brexit, pharma
European health experts have warned that a no-deal Brexit could worsen medicines shortages in the European Union. Speaking to Reuters, …
Senators call on FDA to use “forceful response” against Novartis over faulty data scandal
August 12, 2019Sales and Marketing AveXis, Bernie Sanders, Elizabeth Warren, FDA, Novartis, Zolgensma
Five senators, including presidential candidates Bernie Sanders and Elizabeth Warren, have condemned Novartis for using “falsified data… to obtain approval …
Court sides with Amgen in Sandoz’ challenge over patent on Enbrel
August 12, 2019Sales and Marketing Enbrel, IP, Novartis Amgen, court, patent, pharma
A US court has sided with Amgen in a legal battle over the patent on blockbuster rheumatoid arthritis drug Enbrel. …
Top Ten most popular articles on Pharmafile.com this week!
August 9, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, CAR T, CAR-T, Eli Lilly, Lexicon, Medicare, Novartis, Pfizer, Sanofi, pharma
This week’s top story covered the scandal surrounding Novartis over its covering up of faulty data from the FDA. The …
MS drug boosts effectiveness of cancer therapy in treating glioblastoma, study shows
August 9, 2019Medical Communications MS, brain cancer, glioblastoma, oncology, pharma
The multiple sclerosis (MS) drug teriflunomide boosts the effectiveness of cancer drugs in treating glioblastoma, according to researchers from UC, …
Scientists use duoCAR-T therapy to fight HIV
August 9, 2019Medical Communications AIDS, CAR-T therapy, HIV, health, immunotherapy, pharma
Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …
AstraZeneca’s Tagrisso improves overall survival in lung cancer in Phase 3 trial
August 9, 2019Medical Communications AstraZeneca, Cancer, Tagrisso, lung cancer, oncology, pharma
AstraZeneca has said its cancer drug Tagrisso significantly improved overall survival in a Phase 3 study of patients with lung …
Bayer buys BlueRock Therapeutics for $600 million
August 9, 2019Medical Communications Bayer, BlueRock, acquisitions, cell therapies, pharma
Bayer has entered into an agreement to fully acquire engineered cell therapy firm BlueRock Therapeutics in a deal worth $600 …
Transgene terminates oncolytic IO combo trial in advanced liver cancer
August 8, 2019Research and Development Cancer, Transgene, clinical trials, liver cancer, pharma
Biotech firm Transgene has announced its decision to terminate a study investigating the efficacy of its oncolytic immunotherapy product Pexa-Vec …
Medicare will cover CAR-T therapies in United States
August 8, 2019Sales and Marketing CAR-T therapies, Cancer, Gilead, Kymriah, Medicare, Novartis, keytruda, pharma
Medicare will cover the cost of Novartis’ and Gilead’s CAR-T therapies Kymriah and Yescarta, the US Centers for Medicare and …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
